BMPEA Is A Misbranding Issue For FDA, While Critics Ask Other Questions
This article was originally published in The Tan Sheet
Executive Summary
The agency issues warning letters to five companies addressing a total of eight products with labels listing beta-methylphenethylamine as a dietary ingredient, including two with labels identifying the source as the botanical acacia rigidula.